Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | GEN | CPAY |
|---|---|---|
| Price | $22.09 | $390.60 |
| Change today | ▲ 0.32% | ▲ 0.51% |
| Market cap | $13.22B | $25.65B |
| Return, 3 months | -15.0% | – |
| Return, year to date | -17.5% | – |
| Return, 1 year | -19.9% | – |
| P/E (TTM) | 12.9 | 23.8 |
| P/B | 5.0 | 7.2 |
| P/E percentile vs own 5y | – | 78th |
| Dividend yield | 2.26% | – |
| Revenue growth (YoY, latest qtr) | – | +21.5% |
| Net profit growth (YoY) | – | -11.4% |
| Gross margin | – | 79.0% |
| Operating margin | – | 40.5% |
| Net margin | – | 22.7% |
| Return on equity | – | 30.5% |
| Analyst target vs. price | – | +20.9% |
| Analyst buy share | – | 83% |
| RSI (14) | 28 | – |
| 30-day volatility | 58.0% | – |
| Max drawdown, 1 year | -37.9% | – |
| Trend read | Strong downtrend | – |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
